These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27404513)

  • 1. Derisking Psychiatric Drug Development: The NIMH's Fast Fail Program, A Novel Precompetitive Model.
    Grabb MC; Cross AJ; Potter WZ; McCracken JT
    J Clin Psychopharmacol; 2016 Oct; 36(5):419-21. PubMed ID: 27404513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NIMH during the tenure of Director Herbert Pardes, M.D. (1978-1984): The President's Commission on Mental Health and the reemergence of NIMH's scientific mission.
    Pardes H
    Am J Psychiatry; 1998 Sep; 155(9 Suppl):14-9. PubMed ID: 9736859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Call for Objective Dose Selection to Increase Success in Pediatric Clinical Trials: A Perspective From NICHD and NIMH Program Staff.
    Giacoia G; Grabb MC; Pawlyk AC; Ren Z; Samedy-Bates L; Taylor-Zapata P
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S9-S12. PubMed ID: 34185908
    [No Abstract]   [Full Text] [Related]  

  • 4. Historical highlights of the National Institute of Mental Health from 1946 to the present.
    Judd LL
    Am J Psychiatry; 1998 Sep; 155(9 Suppl):3-8. PubMed ID: 9736857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIMH's Straight and Neural Path: The Road to Killing Clinical Psychiatric Research.
    Markowitz JC; Friedman RA
    Psychiatr Serv; 2020 Nov; 71(11):1096-1097. PubMed ID: 32966168
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrating NIMH's Research Domain Criteria (RDoC) Initiative into Psychiatry Resident Training.
    Cozza EM; Shankman SA
    Acad Psychiatry; 2022 Aug; 46(4):522-527. PubMed ID: 34642858
    [No Abstract]   [Full Text] [Related]  

  • 7. The first implementation of the NIMH FAST-FAIL approach to psychiatric drug development.
    Krystal AD; Pizzagalli DA; Mathew SJ; Sanacora G; Keefe R; Song A; Calabrese J; Goddard A; Goodman W; Lisanby SH; Smoski M; Weiner R; Iosifescu D; Nurnberger J; Szabo S; Murrough J; Shekhar A; Potter W
    Nat Rev Drug Discov; 2018 Dec; 18(1):82-84. PubMed ID: 30591715
    [No Abstract]   [Full Text] [Related]  

  • 8. National Institute of Mental Health: Psychotherapeutic Medications Development Program.
    Haigler HJ; Koslow SH
    J Clin Psychopharmacol; 1992 Aug; 12(4):231-3. PubMed ID: 1527224
    [No Abstract]   [Full Text] [Related]  

  • 9. Joint FDA, NCI program aims to streamline cancer drug development.
    FDA Consum; 2003; 37(4):11. PubMed ID: 12971341
    [No Abstract]   [Full Text] [Related]  

  • 10. An active National Institute of Mental Health.
    Varmus H
    Science; 1995 Jun; 268(5218):1681. PubMed ID: 7792582
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicine. What are the right targets for psychopharmacology?
    Hyman SE; Fenton WS
    Science; 2003 Jan; 299(5605):350-1. PubMed ID: 12532001
    [No Abstract]   [Full Text] [Related]  

  • 12. The National Institute of Mental Health-Psychotherapeutic Medications Development Program (PMDP): status 1993.
    Haigler HJ
    Psychopharmacol Bull; 1994; 30(1):19-22. PubMed ID: 7972624
    [No Abstract]   [Full Text] [Related]  

  • 13. NIMH Drug Trials for Schizophrenia.
    Torrey EF; Yolken RH; Lamb HR
    J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30677268
    [No Abstract]   [Full Text] [Related]  

  • 14. Re-inventing drug development: A case study of the I-SPY 2 breast cancer clinical trials program.
    Das S; Lo AW
    Contemp Clin Trials; 2017 Nov; 62():168-174. PubMed ID: 28899813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety hits mental health institute.
    Marshall E
    Science; 1994 May; 264(5160):764-6. PubMed ID: 8171328
    [No Abstract]   [Full Text] [Related]  

  • 16. [Multicenter psychopharmacologic research and the data bank].
    Cassano GB; Conti L; Massimetti G
    Acta Psychiatr Belg; 1983; 83(3):267-81. PubMed ID: 6356790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Neurobiology to Novel Medications: A Principled Approach to Translation.
    Gordon JA
    Am J Psychiatry; 2019 Jun; 176(6):425-427. PubMed ID: 31154816
    [No Abstract]   [Full Text] [Related]  

  • 18. [NIMH--grant and research system].
    Takayama U
    Seishin Shinkeigaku Zasshi; 1991; 93(6):446-56. PubMed ID: 1891504
    [No Abstract]   [Full Text] [Related]  

  • 19. NIMH-funded pragmatic trials: moving on.
    Wang PS; Insel TR
    Neuropsychopharmacology; 2010 Dec; 35(13):2489-90. PubMed ID: 21068745
    [No Abstract]   [Full Text] [Related]  

  • 20. The Continuing Decline of Clinical Research on Serious Mental Illnesses at NIMH.
    Torrey EF; Simmons WW; Hancq ES; Snook J
    Psychiatr Serv; 2021 Nov; 72(11):1342-1344. PubMed ID: 33820442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.